Intense itch associated with atopic dermatitis (AD) can negatively impact sleep. However, the nature of sleep disturbance and fatigue in AD has not been fully elucidated.
Objectives
The aim of this study was to determine the burden of sleep disturbance and fatigue in US adults with AD.
Methods
This study used a cross-sectional, questionnaire-based survey using a nationally representative sample of 5563 adults from the 2005 to 2006 National Health and Nutrition Examination Survey. Respondents were asked about history of AD, sleep disturbance, and fatigue-related instrumental activity of daily living (IADL) impairment.
Results
There was no significant association between having AD and having a diagnosed sleep disorder (10.44% vs 7.27%; odds ratio [OR] [95% confidence interval (CI)], 1.49 [0.84–2.64]; P = 0.23); however, respondents were more likely to report sleep disturbances to clinicians (33.38% vs 23.67%; OR [95% CI], 1.62 [1.10–2.38]; P = 0.04). In multivariate regression models controlling for sociodemographic and lifestyle factors, adults with AD had higher odds of sleep disturbances, including shorter sleep duration (adjusted OR [95% CI], 1.61 [1.16–2.25]), trouble falling asleep (adjusted OR [95% CI], 1.57 [1.10–2.24]), and early morning awakenings (adjusted OR [95% CI], 1.86 [1.24–22.78]). Those with AD also had significantly higher odds of feeling unrested and feeling too tired to perform IADLs.
Conclusions
United States adults with AD have significantly impaired sleep and fatigue affecting IADLs, and sleep disturbances may be underdiagnosed in this population.
Get full access to this article
View all access options for this article.
References
1.
BeattiePE, Lewis-JonesMS. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact score. Br J Dermatol, 2006; 155(6): 1249–1255.
2.
BenderBG, BallardR, CanonoB, et al.Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol, 2008; 58(3): 415–420.
3.
RicciG, BendandiB, BelliniF, et al.Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol, 2007; 18(3): 245–249.
4.
SilverbergJI, GargNK, PallerAS, et al.Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol, 2015; 135(1): 56–66.
5.
DaleyM, MorinCM, LeBlancM, et al.The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep, 2009; 32(1): 55–64.
6.
RobinsonRL, StephensonJJ, DennehyEB, et al.The importance of unresolved fatigue in depression: costs and comorbidities. Psychosomatics, 2015; 56(3): 274–285.
7.
Yngman-UhlinP, JohanssonA, FernströmA, et al.Fragmented sleep: an unrevealed problem in peritoneal dialysis patients. Scand J Urol Nephrol, 2011; 45(3): 206–215.
8.
ZhangJ, LamSP, LiSX, et al.The longitudinal course and impact of non-restorative sleep: a five-year community-based follow-up study. Sleep Med, 2012; 13(6): 570–576.
9.
HillmanDR, LackLC. Public health implications of sleep loss: the community burden. Med J Aust, 2013; 199(8): S7–S10.
10.
VgontzasAN, LiaoD, BixlerEO, et al.Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep, 2009; 32(4): 491–497.
11.
FerrieJE, KivimäkiM, AkbaralyTN, et al.Change in sleep duration and type 2 diabetes: the Whitehall II study. Diabetes Care, 2015; 38(8): 1467–1472.
12.
SpiegelK, KnutsonK, LeproultR, et al.Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol, 2005; 99(5): 2008–2019.
13.
VgontzasAN, LiaoD, PejovicS, et al.Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care, 2009; 32(11): 1980–1985.
14.
KobayashiD, TakahashiO, DeshpandeGA, et al.Association between weight gain, obesity, and sleep duration: a large-scale 3-year cohort study. Sleep Breath, 2012; 16(3): 829–833.
15.
Navarro-SoleraM, Carrasco-LunaJ, Pin-ArboledasG, et al.Short sleep duration is related to emerging cardiovascular risk factors in obese children. J Pediatr Gastroenterol Nutr, 2015; 61(5): 571–576.
16.
WatanabeM, KikuchiH, TanakaK, et al.Association of short sleep duration with weight gain and obesity at 1-year follow-up: a large-scale prospective study. Sleep, 2010; 33(2): 161–167.
17.
BadranM, YassinBA, FoxN, et al.Epidemiology of sleep disturbances and cardiovascular consequences. Can J Cardiol, 2015; 31(7): 873–879.
18.
SabanayagamC, ShankarA. Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep, 2010; 33(8): 1037–1042.
19.
GrandnerMA, PatelNP, Jean-LouisG, et al.Sleep-related behaviors and beliefs associated with race/ethnicity in women. J Natl Med Assoc, 2013; 105(1): 4–15.
20.
VgontzasAN, LiaoD, PejovicS, et al.Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep, 2010; 33(9): 1159–1164.
21.
RomanosM, GerlachM, WarnkeA, et al.Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health, 2010; 64(3): 269–273.
22.
SchmittJ, ChenCM, ApfelbacherC, et al.Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus. Allergy, 2011; 66(3): 404–411.
23.
AkerstedtT, FredlundP, GillbergM, et al.A prospective study of fatal occupational accidents—relationship to sleeping difficulties and occupational factors. J Sleep Res, 2002; 11(1): 69–71.
24.
GanderPH, MarshallNS, HarrisRB, et al.Sleep, sleepiness and motor vehicle accidents: a national survey. Aust N Z J Public Health, 2005; 29(1): 16–21.
25.
YoungT, BlusteinJ, FinnL, et al.Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep, 1997; 20(8): 608–613.
26.
JetteAM. Toward a common language of disablement. J Gerontol A Biol Sci Med Sci, 2009; 64(11): 1165–1168.
27.
Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: Survey Methods and Analytic Guidelines. Available at: https://www.cdc.gov/nchs/nhanes/survey_methods.htm. Accessed December9, 2015.
28.
HanifinJ, RajkaG. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh), 1980; 92: 44–47.
29.
LawtonMP, BrodyEM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 1969; 9(3): 179–186.
30.
BenjaminiY, HochbergY. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol, 1995; 57: 289–300.
31.
AokiT, KushimotoH, HishikawaY, et al.Nocturnal scratching and its relationship to the disturbed sleep of itchy subjects. Clin Exp Dermatol, 1991; 16(4): 268–272.
32.
BenjaminK, WaterstonK, RussellM, et al.The development of an objective method for measuring scratch in children with atopic dermatitis suitable for clinical use. J Am Acad Dermatol, 2004; 50(1): 33–40.
33.
YanoC, SaekiH, IshijiT, et al.Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. J Dermatol Sci, 2013; 72(2): 195–197.
34.
YanoC, SaekiH, IshijiT, et al.Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol, 2013; 40(9): 736–739.
35.
CicekD, HalisdemirN, DertiogluSB, et al.Increased frequency of restless legs syndrome in atopic dermatitis. Clin Exp Dermatol, 2012; 37(5): 469–476.
36.
HaackM, SanchezE, MullingtonJM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep, 2007; 30(9): 1145–1152.
37.
BurgosI, RichterL, KleinT, et al.Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun, 2006; 20(3): 246–253.
38.
Meier-EwertHK, RidkerPM, RifaiN, et al.Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol, 2004; 43(4): 678–683.
39.
YamadaE, VannaAT, NaspitzCK, et al.International Study of Asthma and Allergies in Childhood (ISAAC): validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children. J Investig Allergol Clin Immunol, 2002; 12(1): 34–41.
40.
ChanHH, PeiA, Van KrevelC, et al.Validation of the Chinese translated version of ISAAC core questions for atopic eczema. Clin Exp Allergy, 2001; 31(6): 903–907.
41.
WeaverTE, LaiznerAM, EvansLK, et al.An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep, 1997; 20(10): 835–843.
